FMP

FMP

Enter

NDRA - ENDRA Life Sciences ...

Financial Summary of ENDRA Life Sciences Inc.(NDRA), ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic u

photo-url-https://financialmodelingprep.com/image-stock/NDRA.png

ENDRA Life Sciences Inc.

NDRA

NASDAQ

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

0.0904 USD

-0.0012 (-1.33%)

About

ceo

Mr. Francois Michelon

sector

Healthcare

industry

Medical - Diagnostics & Research

exchange

NASDAQ

Description

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, ...

CIK

0001681682

ISIN

US29273B3024

CUSIP

29273B104

Address

3600 Green Court

Phone

734 335 0468

Country

US

Employee

21

IPO Date

Jun 30, 2017

Summary

CIK

0001681682

Exchange

NASDAQ

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

29273B104

ISIN

US29273B3024

Country

US

Price

0.09

Beta

0.82

Volume Avg.

20.55M

Market Cap

6.35M

Shares

-

52-Week

0.069-2.79

DCF

0.38

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.1

P/B

-

Website

https://www.endrainc.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest NDRA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep